Pancreatic Cancer Research

ResearcherSun Yat-sen UniversityActive in the last 2 years

Kege Yang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0009-5163-551X; OpenAlex author ID A5062488680. Sources: OpenAlex.

Their work

Papers
10 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
22
Papers, trials and grants by year

2016: 1 paper · 2017: 1 paper · 2018: 3 papers · 2019: none · 2020: none · 2021: none · 2022: 2 papers · 2023: none · 2024: 3 papers

Papers 10

  1. Extracellular vesicle-packaged lncRNA from cancer-associated fibroblasts promotes immune evasion by downregulating HLA-A in pancreatic cancer. Co-author DOI 10.1002/jev2.12484↗
  2. Tumor-associated macrophages drive glycolysis through the IL-8/STAT3/GLUT3 signaling pathway in pancreatic cancer progression. First author DOI 10.1016/j.canlet.2024.216784↗
  3. Glycolysis and tumor progression promoted by the m6A writer VIRMA via m6A-dependent upregulation of STRA6 in pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.canlet.2024.216840↗
  4. Arsenic trioxide-loaded nanoparticles enhance the chemosensitivity of gemcitabine in pancreatic cancer via the reversal of pancreatic stellate cell desmoplasia… Co-author DOI 10.1039/d2bm01039a↗
  5. A LETM2-Regulated PI3K-Akt Signaling Axis Reveals a Prognostic and Therapeutic Target in Pancreatic Cancer. Co-author DOI 10.3390/cancers14194722↗
  6. Tumor-driven like macrophages induced by conditioned media from pancreatic ductal adenocarcinoma promote tumor metastasis via secreting IL-8. Co-author DOI 10.1002/cam4.1824↗
  7. KRAS promotes tumor metastasis and chemoresistance by repressing RKIP via the MAPK-ERK pathway in pancreatic cancer. Co-author DOI 10.1002/ijc.31248↗
  8. MMP1/PAR1/SP/NK1R paracrine loop modulates early perineural invasion of pancreatic cancer cells. Co-author DOI 10.7150/thno.24281↗
  9. Co-delivery of microRNA-21 antisense oligonucleotides and gemcitabine using nanomedicine for pancreatic cancer therapy. Co-author DOI 10.1111/cas.13267↗
  10. A Nanoparticle Carrier for Co-Delivery of Gemcitabine and Small Interfering RNA in Pancreatic Cancer Therapy. Co-author DOI 10.1166/jbn.2016.2269↗

Closest collaborators

The 22 strongest of 22 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Kaihong Huang · 10 shared papers, 2016–2024 · strength 1.23
  2. Yaqing Li · 9 shared papers, 2016–2024 · strength 1.03
  3. Guoda Lian · 8 shared papers, 2016–2024 · strength 0.83
  4. Shaojie Chen · 7 shared papers, 2016–2024 · strength 0.78
  5. Yue Zhao · 4 shared papers, 2022–2024 · strength 0.74
  6. Shurui Zhou · 4 shared papers, 2022–2024 · strength 0.73
  7. Ziyi Zhong · 4 shared papers, 2022–2024 · strength 0.73
  8. Jinmao Zou · 3 shared papers, 2024 · strength 0.59
  9. Hanming Yao · 3 shared papers, 2022–2024 · strength 0.54
  10. Jiajia Li · 3 shared papers, 2018–2024 · strength 0.42
  11. Yinting Chen · 5 shared papers, 2016–2018 · strength 0.35
  12. Linjuan Zeng · 5 shared papers, 2016–2018 · strength 0.35
  13. Yunlong Li · 2 shared papers, 2022–2024 · strength 0.34
  14. Chumei Huang · 4 shared papers, 2017–2018 · strength 0.29
  15. Jiajia Li · 2 shared papers, 2017–2024 · strength 0.25
  16. Shaojie Chen · 1 shared paper, 2024 · strength 0.20
  17. Yuzhou Huang · 1 shared paper, 2024 · strength 0.20
  18. Shangxiang Chen · 1 shared paper, 2022 · strength 0.15
  19. Jiajia Li · 2 shared papers, 2016–2018 · strength 0.14
  20. Qiubo Zhang · 1 shared paper, 2018 · strength 0.08
  21. Jian Li · 1 shared paper, 2018 · strength 0.07
  22. Hong Su · 1 shared paper, 2018 · strength 0.07

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.